BridgeBio to present at multiple healthcare investor conferences in Nov-Dec 2026

BridgeBio Pharma, a biopharmaceutical company focused on genetic conditions, announced its management will participate in investor conferences in London, Miami, and New York during November and December 2026. These presentations will include fireside chats at major healthcare events such as the Jefferies Global Healthcare Conference and the Citi Global Healthcare Conference. Investors can access live webcasts and replays on BridgeBio's website. This engagement highlights BridgeBio's ongoing efforts to communicate its progress and innovations in developing medicines for underserved genetic conditions.

BridgeBio Pharma shares trade at USD 75.96 on Pluang as of Nov 09, 2026 19:42 WIB, up 2.25% in the last day. The stock's market cap stands at $14.47 billion, with a 52-week range from $61.80 to $90.17. Investor interest remains steady with a typical hold time of 65 days on the platform.